Obeticholic acid
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- OCALIVA, INN-Obeticholic Acid
- 207999Orig1s000
- OCALIVA (Obeticholic Acid)
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Angiogenesis As a Potential Therapeutic Target for NASH Treatment
- Obeticholic Acid: First Global Approval
- Future Medical Treatment of PSC
- Novel Therapies for Primary Sclerosing Cholangitis
- Gastrointestinal Drug Advisory Committee (GIDAC) Meeting
- Protein–Ligand Binding with the Coarse-Grained Martini Model
- Nanomedicine: a New Therapeutic Approach in Liver Diseases
- Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin
- Obeticholic Acid (Ocaliva®) Policy #: Rx.01.186
- Klasifikacija ATC 2019
- Ocaliva (Obeticholic Acid) Prior Authorization with Quantity Limit
- Current Management and Future Treatment of Alcoholic Hepatitis
- Obeticholic Acid (Ocaliva®)
- Dostupnost Léčiv Pro Trávicí Trakt a Metabolická Onemocnění: Kouzlo